Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001736069-18-000012
Filing Date
2018-04-02
Accepted
2018-04-02 20:32:41
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 50752
  Complete submission text file 0001736069-18-000012.txt   52203
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Issuer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 OLDE WOODE RD. SALEM NH 03079
Business Address
Gostanian Richard (Reporting) CIK: 0001736069 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-54933 | Film No.: 18731057